Long COVID-19 in children: an Italian cohort study.
COVID-19 in pediatric age
Long COVID-19
Primary care assisted children
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
03 Jun 2022
03 Jun 2022
Historique:
received:
31
01
2022
accepted:
13
05
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
9
6
2022
Statut:
epublish
Résumé
Long COVID-19 syndrome is a complex of symptoms that occurs after the acute SARS-CoV-2 infection, in the absence of other possible diagnoses. Studies on Long COVID-19 in pediatric population are scanty and heterogeneous in design, inclusion criteria, outcomes, and follow-up time. The objective of the present study is to assess the prevalence of Long COVID-19 syndrome in a cohort of Italian pediatric primary care patients, observed for a period of time of 8 to 36 weeks from healing. Prevalence was also assessed in a cohort of pediatric patients hospitalized during acute infection. Data concerning 629 primary care patients with previous acute SARS-CoV-2 infection were collected by a questionnaire filled in by Primary Care Pediatrician (PCP). The questionnaire was administrated to patients by 18 PCPs based in 8 different Italian regions from June to August 2021. Data concerning 60 hospitalized patients were also collected by consultation of clinical documents. Cumulative incidence of Long COVID-19 resulted to be 24.3% in primary care patients and 58% in hospitalized patients. The most frequently reported symptoms were abnormal fatigue (7%), neurological (6.8%), and respiratory disorders (6%) for the primary care cohort. Hospitalized patients displayed more frequently psychological symptoms (36.7%), cardiac involvement (23.3%), and respiratory disorders (18.3%). No difference was observed in cumulative incidence in males and females in both cohorts. Previous diseases did not influence the probability to develop Long COVID-19. The prevalence of Long COVID-19 was 46.5% in children who were symptomatic during acute infection and 11.5% in asymptomatic ones. Children aged 0 to 5 years had a greater risk to develop respiratory symptoms, while adolescents (aged 11-16 years) had a greater risk to develop neurological and psychological Long COVID-19 symptoms. Our study demonstrates that Long COVID-19 is a reality in pediatric age and could involve even patients with mild or no acute symptoms. The results stress the importance of monitoring primary care pediatric patients after acute COVID-19 infection and the relevance of vaccination programs in pediatric population, also in order to avoid the consequences of Long COVID-19 syndrome.
Sections du résumé
BACKGROUND
BACKGROUND
Long COVID-19 syndrome is a complex of symptoms that occurs after the acute SARS-CoV-2 infection, in the absence of other possible diagnoses. Studies on Long COVID-19 in pediatric population are scanty and heterogeneous in design, inclusion criteria, outcomes, and follow-up time. The objective of the present study is to assess the prevalence of Long COVID-19 syndrome in a cohort of Italian pediatric primary care patients, observed for a period of time of 8 to 36 weeks from healing. Prevalence was also assessed in a cohort of pediatric patients hospitalized during acute infection.
METHODS
METHODS
Data concerning 629 primary care patients with previous acute SARS-CoV-2 infection were collected by a questionnaire filled in by Primary Care Pediatrician (PCP). The questionnaire was administrated to patients by 18 PCPs based in 8 different Italian regions from June to August 2021. Data concerning 60 hospitalized patients were also collected by consultation of clinical documents.
RESULTS
RESULTS
Cumulative incidence of Long COVID-19 resulted to be 24.3% in primary care patients and 58% in hospitalized patients. The most frequently reported symptoms were abnormal fatigue (7%), neurological (6.8%), and respiratory disorders (6%) for the primary care cohort. Hospitalized patients displayed more frequently psychological symptoms (36.7%), cardiac involvement (23.3%), and respiratory disorders (18.3%). No difference was observed in cumulative incidence in males and females in both cohorts. Previous diseases did not influence the probability to develop Long COVID-19. The prevalence of Long COVID-19 was 46.5% in children who were symptomatic during acute infection and 11.5% in asymptomatic ones. Children aged 0 to 5 years had a greater risk to develop respiratory symptoms, while adolescents (aged 11-16 years) had a greater risk to develop neurological and psychological Long COVID-19 symptoms.
CONCLUSIONS
CONCLUSIONS
Our study demonstrates that Long COVID-19 is a reality in pediatric age and could involve even patients with mild or no acute symptoms. The results stress the importance of monitoring primary care pediatric patients after acute COVID-19 infection and the relevance of vaccination programs in pediatric population, also in order to avoid the consequences of Long COVID-19 syndrome.
Identifiants
pubmed: 35659358
doi: 10.1186/s13052-022-01282-x
pii: 10.1186/s13052-022-01282-x
pmc: PMC9163526
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
83Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022. The Author(s).
Références
Onder G, Floridia M, Giuliano M, Lo Noce C, Tiple D, Bertinato L, Mariniello R, Laganà MG, Della Vecchia A, Gianferro R, De Feo A, Cosenza P, Di Corcia T, Gianfranco Gensini G, Palummeri E, Frabetti C, Aliberti S, Campana A, Carfì A, Landi F, Rossi A, Cherubini A, Uccelli A, Barisione E, Benedetti L, Bartoloni A, Bonfanti P, Carlesimo M, Guaraldi G, Milic J, Leonardi S, Petrosillo N, Tarsia P. Indicazioni ad interim sui principi di gestione del Long-COVID. Versione del 1° luglio 2021. Roma: Istituto Superiore di Sanità; 2021. (Rapporto ISS COVID-19n. 15/2021). https://www.iss.it . Accessed 30 Oct 2021.
Carfì A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–5. https://doi.org/10.1001/jama.2020.12603 .
doi: 10.1001/jama.2020.12603
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–32. https://doi.org/10.1016/S0140-6736(20)32656-8 Epub 2021 Jan 8. PMID: 33428867; PMCID: PMC7833295. DOI: 10.1016/S0140-6736(20)32656-8.
doi: 10.1016/S0140-6736(20)32656-8
Wan Y-M, Deng X, Tan E-K. Olfattory disfunction and COVID-19. The Lancet Psychiatry. 2020;7(8):663. https://doi.org/10.1016/S2215-0366(20)30253-4 .
doi: 10.1016/S2215-0366(20)30253-4
Velayudhan L, Aarsland D, Ballard C. Psychiatric and Neuropsychiatric syndromes and COVID-19. The Lancet Pshychiatry. 2020;7(8):663–4. https://doi.org/10.1016/S2215-0366(20)30291-1 .
doi: 10.1016/S2215-0366(20)30291-1
https://emergency.cdc.gov/han/2020/han00432.asp . Accessed 17 Mar 2022.
Greenhalgh T, Knight M, A’Court C. Management of post-acute covid-19 in primary care. BMJ. 2020;11(370):m3026. https://doi.org/10.1136/bmj.m3026 .
doi: 10.1136/bmj.m3026
Buonsenso D, Munblit D, De Rose C. Preliminary evidence on Long COVID in children. Acta Paediatr. 2021;110(7):2208–11. https://doi.org/10.1111/apa.15870 .
doi: 10.1111/apa.15870
Zimmermann P, Pittet LF, Curtis N. How Common is Long COVID in Children and Adolescents? Pediatr Infect Dis J. 2021;40(12):e482–7. https://doi.org/10.1097/INF.0000000000003328 .
doi: 10.1097/INF.0000000000003328
Simpson F, Chew-Graham C, Lokugamage A. Long COVID in children: the perspectives of parents and children need to be heard. Br J Gen Pract. 2021;71(706):216. https://doi.org/10.3399/bjgp21X715769 .
doi: 10.3399/bjgp21X715769
https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_15-dicembre-2021.pdf . Accessed 16 Dec 2021.
Sudre CH, Murray B, Varsavsky T. Attributes and predictors of Long COVID. Nat Med. 2021;27(4):626–31. https://doi.org/10.1038/s41591-021-01292-y .
doi: 10.1038/s41591-021-01292-y
Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, Corruble E, Beurnier A, Jutant EM, Pham T, Lecoq AL, Papon JF, Figueiredo S, Harrois A, Humbert M, Monnet X, COMEBAC Study Group. Post-acute COVID-19 syndrome. Eur Respir Rev. 2022;31(163):210185. https://doi.org/10.1183/16000617.0185-2021 PMID: 35264409.
doi: 10.1183/16000617.0185-2021
Osmanov IM, Spiridonova E, Bobkova P. Risk factors for Long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur Respir J. 2021;1:2101341. https://doi.org/10.1183/13993003.01341-2021 .
doi: 10.1183/13993003.01341-2021
Brackel CLH, Lap CR, Buddingh EP. Pediatric Long-COVID: An overlooked phenomenon? Pediatric Pulomonology. 2021;56(8):2495–502. https://doi.org/10.1183/13993003.01341-2021 .
doi: 10.1183/13993003.01341-2021
Asadi-Pooya AA, Nemati H, Shahisavandi M. Long COVID in children and adolescents. World J Pediatr. 2021;17(5):495–9. https://doi.org/10.1007/s12519-021-00457-6 .
doi: 10.1007/s12519-021-00457-6
Buonsenso D, Fusco C, De Rose C, Long COVID in children: Partnerships between families and paediatricians are a priority for better care, J Paediatr Child Health, 2021 Jun 1; https://doi.org/10.1111/jpc.15600 . DOI: https://doi.org/10.1111/jpc.15600